<DOC>
	<DOCNO>NCT02350569</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , antiviral efficacy , pharmacokinetics ledipasvir/sofosbuvir ( LDV/SOF ) fixed-dose combination ( FDC ) administer 4 week adults genotype 1 4 hepatitis C virus ( HCV ) infection undergo primary liver transplantation .</brief_summary>
	<brief_title>Safety Efficacy Ledipasvir/Sofosbuvir Fixed Dose Combination Administered Patients Infected With Chronic Genotype 1 4 HCV Use Peri-Operative Liver Transplantation Setting</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Ledipasvir</mesh_term>
	<mesh_term>Ledipasvir , sofosbuvir drug combination</mesh_term>
	<criteria>Willing able provide write informed consent individual hepatic encephalopathy affect ability provide initial ongoing consent , appropriate legallyauthorized representative ( LAR ) willing able provide consent behalf individual . HCV RNA infection quantifiable virus screen Must chronic genotype 1 4 HCV infection Currently liver transplantation wait list Screening electrocardiogram ( ECG ) without clinically significant abnormality . A negative serum pregnancy test result require female Any previous solid organ transplant Any serious active medical psychiatric illness , opinion investigator , would interfere treatment , assessment , compliance HIV infection positive hepatitis B virus surface antigen result History malignancy Treatment approve experimental medication know antiHCV activity within 1 month prior screen date Prior exposure HCV nonstructural protein ( NS ) 5A inhibitor Patients hemodialysis prior time transplantation exclude Creatinine clearance ( CLcr ) &lt; 40 mL/min screen &lt; 40 mL/min day transplant Participation clinical study investigational drug biologic within 28 day prior screen visit Receipt plan receipt organ HCV positive donor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>liver transplant</keyword>
	<keyword>hepatitis C</keyword>
	<keyword>Gilead</keyword>
	<keyword>Communicable Diseases</keyword>
	<keyword>Infection</keyword>
	<keyword>Virus Diseases</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Hepatitis</keyword>
	<keyword>Hepatitis , Viral , Human</keyword>
	<keyword>Liver Diseases</keyword>
	<keyword>RNA Virus Infections</keyword>
</DOC>